INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS CLICK TO VIEW Table of Contents 2 List of Tables & Charts 3 Study Overview 4 Sample Text, Table & Chart 5 Sample Profile, Table & Forecast 6 Order Form 7 About Freedonia, Custom Research, Related Studies, Corporate Use License 8 Pharmaceuticals in China China Industry Study with Forecasts to 2010 & 2015 Study #2024 | February 2006 | $4800 | 240 pages The Freedonia Group 767 Beta Drive www.freedoniagroup.com Cleveland, OH • 44143-2326 • USA Toll Free US Tel: 800.927.5900 or +1 440.684.9600 Fax: +1 440.646.0484 E-mail: [email protected] Study #2024 February 2006 Pharmaceuticals in China $4800 240 Pages China Industry Study with Forecasts to 2010 & 2015 Table of Contents INTRODUCTION Shipments .......................................62 Corticosteroids ............................ 115 Types of Medicines ............................63 Estrogens & Combinations ............. 115 Astragalus ....................................64 Other Hormones ........................... 116 EXECUTIVE SUMMARY Atractylodes ..................................66 Shipments ..................................... 117 Bupleurum ....................................67 Biologicals & Vaccines ........................ 119 MARKET ENVIRONMENT China Root ....................................67 Demand ......................................... 120 General ..............................................4 Cinnamon .....................................68 Vaccines ..................................... 120 Economic Factors ...................................5 Coptis ..........................................68 Blood & Blood Derivatives ............. 121 Demographic Patterns .............................7 Ephedra ........................................69 Shipments ..................................... 122 Regulated Birth Planning .....................8 Ginger ..........................................70 Nutritional Agents .............................. 123 Mortality Trends ..................................9 Ginseng ........................................70 Demand ......................................... 124 Migration .........................................10 Hoelen .........................................71 Vitamins ..................................... 125 Medical Conditions ...............................10 Licorice ........................................71 Nutrients & Tonics ........................ 126 Acute Conditions ..............................11 Peony ..........................................72 Parenteral Nutritionals .................. 126 Chronic Conditions ............................14 Rehmannia ...................................72 Other Nutritional Agents ............... 127 Health Insurance Coverage ....................16 Rhubarb .......................................72 Shipments ..................................... 127 Basic Medical Insurance .....................17 Salvia...........................................73 Central Nervous System Agents ............. 128 Cooperative Health Insurance .............18 Tang-kuei .....................................74 Demand ......................................... 128 Other Public Health Insurance .............19 Other Traditional Chinese Medicines ..74 Pain Control Agents ...................... 130 Private Health Insurance ....................19 Herbal Combinations ......................76 Psychotherapeutic Agents ............. 130 National Health Expenditures .................20 Other Agents ............................... 131 Medical Providers .................................23 THERAPEUTIC CLAsses Shipments ..................................... 131 Hospitals .........................................24 Respiratory Agents ............................. 133 General ..............................................78 Demand ......................................... 133 Clinics .............................................27 Shipments ..........................................80 Physicians........................................28 Cough/Cold Preparations ............... 134 Anti-Infective Agents ...........................81 Antihistamines ............................ 135 Patient Activity ...................................30 Demand ...........................................82 Hospital Care....................................32 Bronchodilators ........................... 136 Cephalosporins ..............................83 Other Respiratory Agents ............... 137 Surgical Procedures ...........................34 Penicillins .....................................84 Outpatient Visits ...............................34 Shipments ..................................... 137 Other Antibiotics ...........................86 Other Therapeutic Groups .................... 139 Antiviral Agents .............................87 Dermatological Agents ..................... 140 PHARMACEUTICAL OVERVIEW Antifungal Agents ..........................89 Genito-Urinary Agents ..................... 141 General ............................................37 Other Anti-Infective Agents .............90 All Other Therapies .......................... 142 Shipments ..........................................39 Shipments .......................................92 Shipments ..................................... 143 Regulatory Considerations .....................41 Gastrointestinal Agents .........................93 Demand ...........................................94 Product Classification Systems ................41 MARKETS New Product Approval Processes .............42 Antacids & Acid Reducers ................95 Manufacturing Standards .......................43 Proton Pump Inhibitors ..................97 General ............................................ 145 Intellectual Property Rights ...................44 Laxatives ......................................97 Hospitals .......................................... 147 Channels of Distribution ........................44 Antidiarrheal Agents .......................98 Consumer Market ................................ 149 Price Controls ......................................45 Other Gastrointestinal Agents ..........99 Physicians ......................................... 150 Import Requirements ............................46 Shipments ..................................... 100 Clinics & Other Markets ....................... 151 Chinese Trade in Pharmaceuticals ...........47 Cardiovascular Agents ......................... 101 Western Pharmaceuticals .......................48 Demand ......................................... 102 INDUSTRY STRUCTURE Shipments .......................................49 Cardiac Drugs .............................. 103 Antilipemic Agents ....................... 104 General .......................................... 153 Ethical Drugs ....................................50 Market Share ..................................... 154 Generic Drugs ................................52 Antihypertensive Agents ............... 105 Other Cardiovascular Agents .......... 106 Competitive Strategies ........................ 157 Proprietary Drugs ...........................54 Investment ....................................... 163 Shipments ....................................54 Shipments ..................................... 107 Hormones & Related Agents ................. 109 Mergers & Acquisitions ........................ 164 Over-the-Counter (OTC) Drugs .............56 Licensing & Related Agreements ........... 166 Demand Patterns ............................57 Demand ......................................... 109 Antineoplastic Agents ................... 110 Marketing & Distribution ..................... 171 Shipments ....................................59 Manufacturing ................................... 171 Traditional Chinese Medicines ................60 Antidiabetic Agents ...................... 112 Demand Patterns ...............................61 Oral Antidiabetic Agents ............... 113 Click here to purchase online Page 2 Order now, click here! Study #2024 February 2006 Pharmaceuticals in China $4800 240 Pages China Industry Study with Forecasts to 2010 & 2015 Company Profiles List of Tables/Charts AstraZeneca ...................................... 173 EXECUTIVE SUMMARY 2 Pharmaceutical Shipments Bayer AG .......................................... 175 1 Summary Table ................................3 by Therapeutic Group ...................80 Beijing Double-Crane Pharmaceutical .... 177 Cht Pharmaceutical Shipments Beijing Tongrentang ........................... 179 by Therapeutic Class, 2005 ...........81 Bristol-Myers Squibb ........................... 181 MARKET ENVIRONMENT 3 Anti-Infective Agent Demand ...........83 China National Medicines .................... 183 1 Macroeconomic Indicators .................5 4 Anti-Infective Agent Shipments .......93 Chongqing Taiji Industry Group ............ 184 2 Resident Population by Age Group ......8 5 Gastrointestinal Agent Demand ........95 Chongqing Tong Jun Ge ....................... 185 3 Acute Conditions by Type ................11 6 Gastrointestinal Agent Shipments ... 101 GlaxoSmithKline plc ........................... 186 4 Selected Chronic Conditions by Type .15 7 Cardiovascular Agent Demand ........ 102 Guangzhou Pharmaceutical .................. 189 5 Health Insurance Coverage ..............17 8 Cardiovascular Agent Shipments ..... 108 Harbin Pharmaceutical Group ............... 190 6 National Health Expenditures 9 Hormone/Related Agent Demand